Amyloid Activates GSK-3β to Aggravate Neuronal Tauopathy in Bigenic Mice
- 1 March 2008
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 172 (3) , 786-798
- https://doi.org/10.2353/ajpath.2008.070904
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Neuroprotective Effects of Regulators of the Glycogen Synthase Kinase-3β Signaling Pathway in a Transgenic Model of Alzheimer's Disease Are Associated with Reduced Amyloid Precursor Protein PhosphorylationJournal of Neuroscience, 2007
- Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptideNature Reviews Molecular Cell Biology, 2007
- Microtubule Binding and Clustering of Human Tau-4R and Tau-P301L Proteins Isolated from Yeast Deficient in Orthologues of Glycogen Synthase Kinase-3β or cdk5Journal of Biological Chemistry, 2006
- Chronic lithium administration to FTDP‐17 tau and GSK‐3β overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre‐formed neurofibrillary tangles do not revertJournal of Neurochemistry, 2006
- Tau Phosphorylation, Aggregation, and Cell ToxicityBioMed Research International, 2006
- Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapyMolecular Psychiatry, 2004
- Phosphorylation of Tau by Fyn: Implications for Alzheimer's DiseaseJournal of Neuroscience, 2004
- Prominent Cerebral Amyloid Angiopathy in Transgenic Mice Overexpressing the London Mutant of Human APP in NeuronsThe American Journal of Pathology, 2000
- Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cellsCurrent Biology, 1994
- Microtubule‐associated Protein Tau, Paired Helical Filaments, and PhosphorylationaAnnals of the New York Academy of Sciences, 1993